Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced …

G McIlroy, E Nikolousis, N Abou-Zeid… - Leukemia & …, 2020 - Taylor & Francis
Reduced intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation
(allo-HSCT) has transformed the management of older or infirm patients suffering from …
被引用次数：1 相关文章

[引用][C] Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based …

G McIlroy, E Nikolousis, N Abou-Zeid… - Leukemia & …, 2019 - europepmc.org
Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell
chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab …

Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced …

G McIlroy, E Nikolousis, N Abou-Zeid… - Leukemia & …, 2020 - pubmed.ncbi.nlm.nih.gov
Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently
associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic …

[引用][C] Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based …

G McIlroy, E Nikolousis… - Leukemia and …, 2020 - research.birmingham.ac.uk
Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently
associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic …

[引用][C] Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based …

G McIlroy, E Nikolousis, N Abou-Zeid… - Leukemia & …, 2020 - eprints.whiterose.ac.uk
Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently
associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic …